logo

For the Inventor, By the Inventor

Horsham, United Kingdom

Graham Charles Bloomfield

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 9.4

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • West Sussex, GB (2010)
  • Broadbridge Heath, GB (2014)
  • Horsham, GB (2011 - 2018)

Company Filing History:

goldMedal12 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2010-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 10112926 - Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors (2018-10-30),
2. 10004732 - Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors (2018-06-26),
3. 9643983 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives (2017-05-09),
4. 9303035 - Substituted pyrazino[1',2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel (2016-04-05),
5. 9139586 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives (2015-09-22),
6. 8901134 - Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders (2014-12-02),
7. 8697687 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives (2014-04-15),
8. 8129541 - 5-phenylthiazole derivatives and use as PI3 kinase inhibitors (2012-03-06),
9. 8039472 - Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel (2011-10-18),
10. 8017608 - 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors (2011-09-13),
11. 7902375 - 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases (2011-03-08),
12. 7687637 - 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors (2010-03-30),

Title: Innovations of Graham Charles Bloomfield

Introduction

Graham Charles Bloomfield is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on developing compounds that target specific biological pathways.

Latest Patents

Among his latest patents are "Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors" and "Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors." Both inventions provide compounds that inhibit the activity of the PI 3-kinase gamma isoform, which is crucial for treating diseases mediated by its activation.

Career Highlights

Graham Bloomfield is currently associated with Novartis AG, a leading global healthcare company. His innovative work has positioned him as a key player in the development of new therapeutic agents.

Collaborations

Throughout his career, Graham has collaborated with esteemed colleagues such as Ian Bruce and Lee Edwards. These partnerships have enhanced the scope and impact of his research.

Conclusion

Graham Charles Bloomfield's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…